Clinical Trials in Anyang, China
Locations / Anyang, China
Delta Trials lists 177 clinical trials conducted in Anyang, China, making it a notable site of clinical research activity. These trials addressing 168 medical conditions, reflecting the scope and diversity of clinical research in this location. Since 2020, 3 trials in this location have been terminated before reaching their primary endpoint. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the Anyang research landscape.
177
Total Trials
168
Conditions
3
Terminated since 2020
Browse by condition (168 total)
- Breast cancer 12 trialsAll Breast cancer trials
- Acute ischemic stroke 11 trialsAll Acute ischemic stroke trials
- Non-small cell lung cancer 11 trialsAll Non-small cell lung cancer trials
- Esophageal squamous cell carcinoma 8 trialsAll Esophageal squamous cell carcinoma trials
- Esophageal cancer 7 trialsAll Esophageal cancer trials
- Breast neoplasms 5 trialsAll Breast neoplasms trials
- Esophagus cancer 5 trialsAll Esophagus cancer trials
- Advanced solid tumors 4 trialsAll Advanced solid tumors trials
- Her2-positive breast cancer 4 trialsAll Her2-positive breast cancer trials
- Ischemic stroke, acute 4 trialsAll Ischemic stroke, acute trials
- Immunotherapy 4 trialsAll Immunotherapy trials
- All Gastroesophageal junction adenocarcinoma trials
- Transient ischemic attack 3 trialsAll Transient ischemic attack trials
- All Locally advanced or metastatic breast cancer trials
- Chemoradiotherapy 3 trialsAll Chemoradiotherapy trials
- Gastric cancer 3 trialsAll Gastric cancer trials
- Atopic dermatitis 3 trialsAll Atopic dermatitis trials
- Metastatic breast cancer 3 trialsAll Metastatic breast cancer trials
- Basilar artery occlusion 2 trialsAll Basilar artery occlusion trials
- Ischemic stroke 2 trialsAll Ischemic stroke trials